Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP562858.RAtZsCBAmTKv54nYWyTSys6AP_Ul2xv-GvUeq69h9fgXs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP562858.RAtZsCBAmTKv54nYWyTSys6AP_Ul2xv-GvUeq69h9fgXs130_assertion type Assertion NP562858.RAtZsCBAmTKv54nYWyTSys6AP_Ul2xv-GvUeq69h9fgXs130_head.
- NP562858.RAtZsCBAmTKv54nYWyTSys6AP_Ul2xv-GvUeq69h9fgXs130_assertion description "[Twelve of these genes (RASSF1A, p16(INK4A), TSHR, MGMT, DAPK, ERalpha, ERbeta, RARbeta, PTEN, CD26, SLC5A8, and UCHL1) were frequently methylated in UTC (15%-86%) and thyroid cancer cell lines (25%-100%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562858.RAtZsCBAmTKv54nYWyTSys6AP_Ul2xv-GvUeq69h9fgXs130_provenance.
- NP562858.RAtZsCBAmTKv54nYWyTSys6AP_Ul2xv-GvUeq69h9fgXs130_assertion evidence source_evidence_literature NP562858.RAtZsCBAmTKv54nYWyTSys6AP_Ul2xv-GvUeq69h9fgXs130_provenance.
- NP562858.RAtZsCBAmTKv54nYWyTSys6AP_Ul2xv-GvUeq69h9fgXs130_assertion SIO_000772 16889486 NP562858.RAtZsCBAmTKv54nYWyTSys6AP_Ul2xv-GvUeq69h9fgXs130_provenance.
- NP562858.RAtZsCBAmTKv54nYWyTSys6AP_Ul2xv-GvUeq69h9fgXs130_assertion wasDerivedFrom befree-2016 NP562858.RAtZsCBAmTKv54nYWyTSys6AP_Ul2xv-GvUeq69h9fgXs130_provenance.
- NP562858.RAtZsCBAmTKv54nYWyTSys6AP_Ul2xv-GvUeq69h9fgXs130_assertion wasGeneratedBy ECO_0000203 NP562858.RAtZsCBAmTKv54nYWyTSys6AP_Ul2xv-GvUeq69h9fgXs130_provenance.